Track Hims & Hers Health, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Hims & Hers Health, Inc. HIMS · Stock Open Hims & Hers Health, Inc. in new tab

19.73 USD
P/E
53.27
EPS
-0.83
P/B
13.01
ROE
-40.77
Beta
2.50
Target Price
28.31 USD
Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc.

🧾 Earnings Recap – Q3 2026

Hims & Hers fell 16.6% after earnings, as investors appear to have focused on management’s planned trade-off of near-term subscriber growth for longer-term positioning. The company said it pulled back on weight-loss marketing and will redeploy investment ahead of the new year, while emphasizing future opportunities rather than near-term growth.

  • Revenue growth accelerated to nearly 50%, according to management.
  • Nearly 3 million people across four continents use the platform.
  • Management said it intentionally reduced weight-loss marketing as it prepared new offerings and international investment, acknowledging this trades near-term subscriber growth for a stronger future position.
  • The company plans to put its next wave of marketing investment to work ahead of the new year, when management expects seasonal interest in weight loss to peak.
  • Hims & Hers said it is launching testosterone replacement therapy this quarter and Peptides+ later this month.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 22, 2027
P/E53.27
EPS-0.83
Book Value1.52
Price to Book13.01
Debt/Equity439.28
% Insiders6.952%
Growth
Revenue Growth0.49%
Earnings Growth-0.17%
Estimates
Forward P/E48.84
Forward EPS0.40
Target Mean Price28.31

DCF valuation

Model fair value for Hims & Hers Health, Inc. (HIMS)
Result
Sign in to run the valuation for HIMS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
13 analysts · consensus Hold · mean target 28.31 USD (low 23.00, high 40.00) · as of 15 Nov 2026
Low 23.00
Mean 28.31
High 40.00
Price 19.73
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Hims & Hers Health, Inc. Logo Hims & Hers Health, Inc. Analysis (HIMS)

United States Consumer Staples Official Website Stock

Is Hims & Hers Health, Inc. a good investment? Hims & Hers Health, Inc. (HIMS) is currently trading at 19.73 USD. Market analysts have a consensus price target of 28.31 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 53.27. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Hims & Hers Health, Inc. is expected to release its next earnings report on Feb. 22, 2027. The market consensus estimate for Forward EPS is 0.40.

Investor FAQ

Does Hims & Hers Health, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Hims & Hers Health, Inc.?

Hims & Hers Health, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 22, 2027. The company currently has a trailing EPS of -0.83.

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Exchange Ticker
NYQ (United States) HIMS
FRA (Germany) 82W.F
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion